Financhill
Back

ProShares Ultra Nasdaq Biotechnology Vs. ProShares Ultra Real Estate Industry Stock Comparison

Sell
43

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
57.90
Seasonality Move:
16.48%
Buy
75

URE
ProShares Ultra Real Estate

Last Price:
76.00
Seasonality Move:
4.21%
Sell
43
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?

  • The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $58.30. The Score for BIB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
ProShares Ultra Real Estate (URE) is a Buy

Is ProShares Ultra Real Estate a Buy, Sell or Hold?

  • The current ProShares Ultra Real Estate [URE] share price is $75.12. The Score for URE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • URE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIB Stock Price Chart

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

  • The ProShares Ultra Nasdaq Biotechnology share price today is $58.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight selling pressure.

URE Stock Price Chart

What is ProShares Ultra Real Estate's stock price today?

  • The ProShares Ultra Real Estate share price today is $75.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URE is experiencing slight buying pressure.

BIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.02 Sell
Relative Strength Index (14 RSI): 45.1 Sell
Chaikin Money Flow: -5442 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.65 - 64.63) Sell
Bollinger Bands (100): (60.25 - 66.99) Sell

URE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 59.23 Buy
Chaikin Money Flow: 2858 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.05 - 73.75) Buy
Bollinger Bands (100): (65.33 - 75.25) Buy

BIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.51 Buy
20-day SMA: 60.19 Sell
50-day SMA: 62.23 Sell
200-day SMA: 59.93 Sell
8-day EMA: 57.02 Buy
20-day EMA: 59.17 Sell
50-day EMA: 61.35 Sell
200-day EMA: 60.12 Sell

URE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.66 Buy
20-day SMA: 71.34 Buy
50-day SMA: 73.18 Buy
200-day SMA: 63.36 Buy
8-day EMA: 72.4 Buy
20-day EMA: 71.99 Buy
50-day EMA: 71.87 Buy
200-day EMA: 65.67 Buy

ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra Real Estate Earnings Growth & URE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra Nasdaq Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProShares Ultra Real Estate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):